Rewriting the Dementia Playbook: A Value-Based Blueprint for Brain Health
As dementia diagnoses rise and new treatments emerge, health systems face both an urgent challenge and a strategic opportunity: how to evolve care models to identify, triage, and treat cognitive impairment earlier — while aligning with value-based care goals.
Join us for a forward-looking conversation on how leading health systems and physician practices are redefining dementia care for the value-based era. Learn how proactive brain health strategies — rooted in early detection, digital innovation, and coordinated care — are improving patient outcomes, streamlining resource utilization, and unlocking new performance gains in risk-based models.
Watch the on-demand webinar
Watch the webinar to learn how to:
-
Design and scale brain health programs across care settings
Learn how to build and operationalize scalable cognitive health initiatives that integrate primary care, geriatrics, and neurology — starting with risk identification and stratification.
-
Detect and manage cognitive impairment earlier and more efficiently
Discover how digital tools and coordinated triage workflows help identify at-risk patients before symptoms escalate, streamline referrals, and ensure timely, appropriate interventions.
-
Drive value-based outcomes through proactive brain health management
Understand how early detection and intervention improve population health, enhance HCC coding accuracy, boost RAF performance, and close the cognitive screening gap across patient populations.
Hear from an expert panel:
Phyllis Ferrell, DrPH, MBA
Phyllis Ferrell is an innovator, investor, and incubator for brain health and longevity. After three decades as a life sciences executive at Eli Lilly & Company, Phyllis retired from the pharmaceutical business and is now working as an independent advisor for multiple non-profit and private sector clients and is a Nonresident Scholar and the Managing Director of the Clinical Trial Recruitment Lab (CTRL) at the USC Schaeffer Center. Additionally, she is on the Board of Overseers for the Alzheimer’s Drug Discovery Foundation (ADDF), is a contributor on brain health for the Forbes Business Council, and is the Chief Impact Officer for the StartUp Health Alzheimer’s Moonshot, a global initiative that aims to break down silos and foster meaningful collaboration and entrepreneurial support between mission-aligned founders and champions.
John Showalter, MD
Chief Strategy Officer, Linus Health
Dr. Showalter is the Chief Strategy Officer at Linus Health and a dual board-certified primary care physician. As the Chief Product Officer, he is responsible for the integrated strategy for the product, medical, and analytics teams. Prior to joining Linus Health, he spent five years as Chief Product Officer at Jvion, a leader in clinical AI. His experience also includes 10 years at health systems, most recently serving as CMIO and CHIO at the University of Mississippi Medical Center, where he also practiced clinically in family medicine.